BPMC — Blueprint Medicines Share News
0.000.00%
Last trade - 00:00- $8.37bn
- $8.18bn
- $508.82m
Brief: Blueprint Medicines Announces Data Reinforcing Safety Profile Of Long-Term Ayvakit
U.S. STOCKS ON THE MOVE-Texas Instruments, Broadcom, Circle
UBS raises Blueprint Medicines' PT on Sanofi's up to $9.5 billion takeover deal
U.S. RESEARCH ROUNDUP-Biomea Fusion, GE Aerospace, P&G
U.S. STOCKS ON THE MOVE-Natgas companies, UnitedHealth, Cactus
U.S. STOCKS ON THE MOVE-Lyra Therapeutics, Church & Dwight, Applied Digital
Blueprint Medicines hits record high on Sanofi's $9 bln buyout offer
U.S. STOCKS ON THE MOVE-Xilio Therapeutics, Red Rock Resorts, Kymera
Brief: Blueprint Medicines Corp - Sanofi To Pay $500 Mln To Co If Deal Is Terminated Under Certain Circumstances
U.S. STOCKS ON THE MOVE-Moderna, Blueprint Medicines, Boeing
Sanofi finds M&A fix for its multiple itches
Blueprint Medicines gains on Sanofi's $9 bln buyout offer
Sanofi buys US biopharma group Blueprint in $9.1 bln deal (updated)
Sanofi buys US biopharma group Blueprint in $9.1 bln deal
Brief: Sanofi To Acquire Blueprint Medicines
Blueprint Medicines Corp reports results for the quarter ended March 31 - Earnings Summary
Blueprint Medicines Corp expected to post a loss of 52 cents a share - Earnings Preview
Blueprint Medicines Corp reports results for the quarter ended December 31 - Earnings Summary
Brief: Blueprint Medicines Q4 Net Income USD -49.956 Million Vs. IBES Estimate USD -44.7 Million